List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1172 studies with search of: "Paclitaxel"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
Condition: Occult Primary
Interventions: Drug: belinostat, carboplatin, paclitaxel;   Drug: carboplatin, paclitaxel
2 Terminated Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: PF-3512676 + Paclitaxel + Carboplatin;   Drug: Paclitaxel + Carboplatin
3 Not yet recruiting Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Sunitinib;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Sunitinib
4 Not yet recruiting Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver
Conditions: Melanoma;   Liver Metastasis
Intervention: Drug: Nab-Paclitaxel (Abraxane)
5 Terminated Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: paclitaxel + carboplatin + bevacizumab;   Drug: carboplatin + paclitaxel + bevacizumab + PF-3512676
6 Not yet recruiting A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Conditions: Solid Tumors;   Ovarian Cancer
Interventions: Drug: OSI-906 and Paclitaxel;   Drug: OSI-906 and Paclitaxel;   Drug: OSI-906 and Paclitaxel
7 Recruiting A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Sunitinib;   Drug: paclitaxel;   Drug: bevacizumab;   Drug: paclitaxel
8 Active, not recruiting Study of Dose-Dense Adriamycin Plus Cytoxan (AC) Followed by Either Abraxane or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Cytoxan;   Drug: Neulasta;   Drug: Bevacizumab;   Drug: ABI-007;   Drug: Taxol;   Drug: Adriamycin;   Drug: ABI-007 plus Bevacizumab;   Drug: ABI-007 plus Bevacizuman;   Drug: ABI-007 plus Bevacizumag;   Drug: ABI-007 plus Bevacizumab
9 Active, not recruiting Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
Condition: Coronary Restenosis
Interventions: Drug: ABI-007;   Drug: ABI-007;   Drug: ABI-007;   Drug: ABI-007
10 Active, not recruiting Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer
Condition: Neoplasm
Interventions: Drug: Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU);   Drug: Paclitaxel for injection (Taxol)
11 Completed Pharmacokinetics Study of Liposomal Paclitaxel in Humans
Condition: Cancer
Interventions: Drug: Liposomal paclitaxel;   Drug: Paclitaxel
12 Recruiting PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Tubal Cancer
Intervention: Drug: Dasatinib, Paclitaxel, and Carboplatin
13 Recruiting The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions
Conditions: Coronary Artery Disease;   Chronic Total Occlusion;   Native Coronary Artery
Interventions: Device: paclitaxel eluting PTCA balloon catheter (SeQuent Please);   Device: paclitaxel eluting Taxus stent (Boston Scientific)
14 Recruiting Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head & Neck Cancer
Intervention: Other: Cetuximab, IMRT, Albumin-bound paclitaxel (Abraxane®)
15 Recruiting Hepatic Arterial Infusion (HAI) of Abraxane
Conditions: Liver Cancer;   Advanced Cancers;   Solid Tumors
Interventions: Drug: Abraxane;   Procedure: Hepatic Artery Catheter
16 Recruiting A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Interventions: Drug: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Procedure: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Drug: Carboplatin and Paclitaxel and Radiation Therapy
17 Recruiting A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.
Conditions: Non-Small-Cell Lung Carcinoma;   Adenocarcinoma
Interventions: Drug: Bevacizumab + Carboplatin + Paclitaxel;   Drug: AG-013736 (axitinib) + Carboplatin + Paclitaxel
18 Recruiting Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
Conditions: Metastatic Breast Cancer;   First or Second Line Therapy
Intervention: Drug: Lapatinib/nab-Paclitaxel
19 Recruiting Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Paclitaxel
20 Not yet recruiting Study of Pazopanib and Paclitaxel in Advanced Non-Small Cell Lung Cancer
Conditions: Advanced Non-Small Cell Lung Cancer;   Advanced Solid Tumor;   Metastatic Non-Small Cell Lung Cancer
Interventions: Drug: pazopanib + paclitaxel;   Drug: paclitaxel + carboplatin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options